CHERTSEY, England, January 16, 2015 /PRNewswire/ --
$150,000 Grant will be awarded on Saturday 24thJanuary
The Astellas European Foundation has announced the shortlist for the Transplantation Grant. The Grant programme supports basic medical and related scientific programmes which contribute to advancements in transplantation. The five finalists are from Denmark, Germany, The Netherlands, Romania, and Switzerland. The winner will be announced at the Advancing Transplantation Meeting, being held at the Karonlinska Institutet, Stockholm, Sweden, between 24th and 26th January, 2015.
The shortlisted projects:
Professor Allan Rasmussen, Rigshospitalet, Copenhagen, Denmark, 'Donor Specific Antibodies in Liver Transplantation: a prospective blinded multicenter prognostic study'
Dr. Robert Öllinger, Charité Virchow Klinikum, Berlin, Germany, 'Bariatric procedures in morbidly obese patients with renal insufficiency to enable kidney transplantation'
Dr Gertrude Nieuwenhuijs-Moeke, University Medical Centre Groningen, The Netherlands, 'Volatile Anesthetic Protection of Renal Transplants-2'
Professor Ilhan Inci, University Hospital Zurich, Switzerland, 'Randomized placebo controlled trial of N-acetylcysteine in a pig lung transplant survival model'
Professor Irinel Popescu, Fundeni Clinical Institute, Bucharest, Romania, 'Association of de novo donor specific anti-HLA antibodies and liver allograft outcome according to ABCB1 and CYP3A5 genotypes'
The Astellas European Foundation is a registered charity with the long-term goal of providing support for programmes and activities that advance our understanding of medicine and health. The winner of the Grant is selected by a Judging Faculty that includes independent European thought leaders.
Dr Ayad Abdulahad, Astellas European Foundation Trustee and Senior Vice President of Medical Affairs and Health Economics for Astellas Pharma EMEA commented: "We received a record 98 applications from research institutions and hospitals across Europe. The Foundation looks forward to announcing the winner later this month and is pleased to share the shortlist entrants who have succeeded in reaching the final stage. We would like to thank all the institutions that have expressed their interest with applications."
The Foundation now offers annual Grants of $150,000 for Uro-Oncology, Functional Urology and Uro-Gynaecology, and Transplantation. For information regarding the Grant process please contact the Astellas European Foundation by email at aef@astellas.com or call +44-203-379-8039.
Notes to Editors
About The Astellas European Foundation
The Astellas European Foundation is a registered charity, formed in 2005, with the long-term goal of providing support for programmes and activities that contribute to the advancement of an increasingly healthy society. In line with this aim, the Foundation has made substantial donations to global charities. The Astellas European Foundation also supports Astellas employees in their private fundraising efforts for charitable causes. The Astellas European Foundation is registered with the Charity Commission for England and Wales, number 1036344.
The Astellas European Foundation was established by funding from Astellas Pharma Inc, but operates independently of it.
